Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Identification of novel regions of deletion in familial Wilms' tumor by comparative genomic hybridization.

Altura RA, Valentine M, Li H, Boyett JM, Shearer P, Grundy P, Shapiro DN, Look AT.

Cancer Res. 1996 Aug 15;56(16):3837-41.

2.

The WT1 Wilms' tumor suppressor gene: how much do we really know?

Reddy JC, Licht JD.

Biochim Biophys Acta. 1996 May 16;1287(1):1-28. Review. No abstract available.

PMID:
8639704
3.

Truncated WT1 mutants alter the subnuclear localization of the wild-type protein.

Englert C, Vidal M, Maheswaran S, Ge Y, Ezzell RM, Isselbacher KJ, Haber DA.

Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):11960-4.

4.

Characterization of regions of chromosomes 12 and 16 involved in nephroblastoma tumorigenesis.

Austruy E, Candon S, Henry I, Gyapay G, Tournade MF, Mannens M, Callen D, Junien C, Jeanpierre C.

Genes Chromosomes Cancer. 1995 Dec;14(4):285-94.

PMID:
8605117
5.
6.
7.
8.

Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.

Park S, Tomlinson G, Nisen P, Haber DA.

Cancer Res. 1993 Oct 15;53(20):4757-60.

9.

WT-1 is required for early kidney development.

Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R.

Cell. 1993 Aug 27;74(4):679-91.

PMID:
8395349
11.

The role of WT1 in Wilms tumorigenesis.

Coppes MJ, Campbell CE, Williams BR.

FASEB J. 1993 Jul;7(10):886-95. Review.

PMID:
8393819
12.

Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product.

Werner H, Re GG, Drummond IA, Sukhatme VP, Rauscher FJ 3rd, Sens DA, Garvin AJ, LeRoith D, Roberts CT Jr.

Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5828-32.

13.

Physical and functional interaction between WT1 and p53 proteins.

Maheswaran S, Park S, Bernard A, Morris JF, Rauscher FJ 3rd, Hill DE, Haber DA.

Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5100-4.

14.

The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo.

Armstrong JF, Pritchard-Jones K, Bickmore WA, Hastie ND, Bard JB.

Mech Dev. 1993 Jan;40(1-2):85-97.

PMID:
8382938
15.

Evidence for physical interaction between the zinc-finger transcription factors YY1 and Sp1.

Lee JS, Galvin KM, Shi Y.

Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6145-9.

16.

Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues.

Mundlos S, Pelletier J, Darveau A, Bachmann M, Winterpacht A, Zabel B.

Development. 1993 Dec;119(4):1329-41.

17.

WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant.

Haber DA, Park S, Maheswaran S, Englert C, Re GG, Hazen-Martin DJ, Sens DA, Garvin AJ.

Science. 1993 Dec 24;262(5142):2057-9.

PMID:
8266105
18.

DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1.

Drummond IA, Rupprecht HD, Rohwer-Nutter P, Lopez-Guisa JM, Madden SL, Rauscher FJ 3rd, Sukhatme VP.

Mol Cell Biol. 1994 Jun;14(6):3800-9.

19.

Mutations of the p53 tumor suppressor gene occur infrequently in Wilms' tumor.

Malkin D, Sexsmith E, Yeger H, Williams BR, Coppes MJ.

Cancer Res. 1994 Apr 15;54(8):2077-9.

20.

Nuclear localization of p85s6k: functional requirement for entry into S phase.

Reinhard C, Fernandez A, Lamb NJ, Thomas G.

EMBO J. 1994 Apr 1;13(7):1557-65.

Supplemental Content

Support Center